癌症流行病学中的个体脆弱性超额风险模型
针对癌症生存研究中未观测个体异质性导致的模型误设和变量缺失问题,提出个体超额风险脆弱性模型,将脆弱性建模扩展至相对生存框架,采用闭合形式边际风险与生存函数便于推断,通过模拟研究和英格兰肺癌患者数据展示方法性能,并讨论忽略未观测异质性对净生存估计的影响。
要点
- 提出个体超额风险脆弱性模型,将脆弱性建模扩展至相对生存框架。
- 选用产生闭合形式边际风险与生存函数的脆弱性分布以便参数推断。
- 通过模拟研究和英格兰肺癌数据示例展示方法性能。
核心结论
- 提出个体超额风险脆弱性模型以考虑个体异质性,该模型是脆弱性建模在相对生存框架下的扩展。
研究设计与样本
- 方法学研究,提出个体超额风险脆弱性模型,通过模拟研究评估方法性能,并应用于英格兰肺癌患者数据。
主要发现
- 所选脆弱性分布产生闭合形式边际风险与生存函数,模型允许直观解释,即脆弱性导致幸存者中较健康个体的选择。
- 采用具有一般风险结构的灵活参数模型建模超额风险,便于纳入时依效应。
- 使用英格兰肺癌患者数据示例,讨论未考虑未观测异质性对净生存估计的影响。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Unobserved individual heterogeneity is a common challenge in population cancer survival studies. This heterogeneity is usually associated with the combination of model misspecification and the failure to record truly relevant variables. We investigate the effects of unobserved individual heterogeneity in the context of excess hazard models, one of the main tools in cancer epidemiology. We propose an individual excess hazard frailty model to account for individual heterogeneity. This represents an extension of frailty modeling to the relative survival framework. In order to facilitate the inference on the parameters of the proposed model, we select frailty distributions which produce closed-form expressions of the marginal hazard and survival functions. The resulting model allows for an intuitive interpretation, in which the frailties induce a selection of the healthier individuals among survivors. We model the excess hazard using a flexible parametric model with a general hazard structure which facilitates the inclusion of time-dependent effects. We illustrate the performance of the proposed methodology through a simulation study. We present a real-data example using data from lung cancer patients diagnosed in England, and discuss the impact of not accounting for unobserved heterogeneity on the estimation of net survival. The methodology is implemented in the R package IFNS.
引用
- Rubio FJ, Putter H, Belot A, et al. Individual frailty excess hazard models in cancer epidemiology. Stat Med. 2023. PMID: 36694108. doi:10.1002/sim.9657
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。